Global News

AstraZeneca in A5 alliance for Alzheimer’s

Friday, July 13, 2012 03:14 PM

AstraZeneca and Dr. Steven Paul of Weill Cornell Medical College have announced a first of its kind research alliance that brings four leading academic research laboratories together with AstraZeneca to study a major risk factor for Alzheimer's disease, the apolipoprotein E4 genotype (ApoE).

More... »

Lilly pomaglumetad methionil study falls short of primary endpoint

Thursday, July 12, 2012 04:35 PM

Eli Lilly reported negative clinical trial results from study H8Y-MC-HBBM (HBBM) investigating pomaglumetad methionil, also known as mGlu2/3, for the treatment of acute exacerbation of schizophrenia.

More... »

Allscripts, Quintiles to develop software solutions for clinical and post-approval research

Thursday, July 12, 2012 12:37 PM

Quintiles, a fully integrated biopharmaceutical services company, and Allscripts, a software company, have entered a strategic partnership to jointly develop software solutions to enable improvements to the drug development process and demonstrate the value of biopharma products in the real world.

More... »

23andMe acquires CureTogether

Thursday, July 12, 2012 11:22 AM

Personal genetics company 23andMe has completed its first acquisition with the purchase of CureTogether, launched in 2008 to help people who live in daily chronic pain.

More... »

Study: U.S. provides faster access to oncology drugs than Europe

Thursday, July 12, 2012 11:01 AM

Cancer patients in the U.S. get faster access to more oncology drugs to treat their disease than patients in Europe, according to a recent study by the Boston-based Tufts Center for the Study of Drug Development.

More... »

Genova Diagnostics acquires Metametrix

Wednesday, July 11, 2012 09:17 AM

Genova Diagnostics, a global specialty clinical laboratory based in Asheville, N.C., has decided to acquire Metametrix, a clinical laboratory in Duluth, Ga.

More... »

Janssen buys exclusive access to Evotec's insulin-producing beta cells

Tuesday, July 10, 2012 04:25 PM

Evotec, a drug discovery alliance and development partnership company, has licensed a portfolio of small molecules and biologics designed to trigger the regeneration of insulin-producing beta cells to Janssen Pharmaceuticals.

More... »

Abbott, ChemDiv Research ink Russian R&D collaborations

Tuesday, July 10, 2012 03:30 PM

Abbott Laboratories, a global healthcare company, and ChemDiv Research Institute (CDRI), the research entity of ChemRar Hi-Tech Centre, have signed an agreement to launch several R&D projects in Russia.

More... »

HeartWare names Peter F. McAree as CFO

Monday, July 9, 2012 04:48 PM

HeartWare International, a developer of less invasive, miniaturized circulatory support technologies for treatment of advanced heart failure, has appointed Peter F. McAree as senior vice president, CFO and Treasurer

More... »

Genkyotex raises $26M in Series C round extension

Monday, July 9, 2012 04:01 PM

Genkyotex, a Swiss developer of NOX inhibitors to treat oxygen-radical mediated diseases, has closed a $26 million extension to its Series C financing. Investors in the Series C round, including Eclosion, Edmond de Rothschild Investment Partners, Vesalius Biocapital Partners, MP Healthcare Venture, all participated in the financing extension.

More... »